{"brief_title": "Consistency Lots Vaccine Study (V260-009)", "brief_summary": "This study was designed to evaluate consistency in the antibody response to three manufactured lots of an investigational Rotavirus Vaccine.", "condition": "Rotavirus Infections", "intervention_type": "Biological", "intervention_name": "Placebo", "description": "Placebo-matching RotaTeq\u2122 administered at 3 separate visits scheduled 4 to 10\nweeks (28 to 70 days) apart with up to 42 days of safety follow up after each vaccination", "arm_group_label": "Placebo", "other_name": "RotaTeq\u2122", "criteria": "Inclusion Criteria: - Healthy infants Exclusion Criteria: - History of abdominal disorders from a birth defect, intussusception, or abdominal surgery - Known or suspected problems with the immune system - Fever at time of immunization - Prior administration of a rotavirus vaccine - History of known prior rotavirus disease, chronic diarrhea, or failure to thrive.", "gender": "All", "minimum_age": "6 Weeks", "maximum_age": "12 Weeks", "healthy_volunteers": "Accepts Healthy Volunteers", "id": "NCT00092456.xml"}